Crossbow Therapeutics

Crossbow Therapeutics

Edit info

  • Founded: 2022

  • Location: Cambridge, MA

  • Employee range: 11 - 50

  • Clinical stage: RD

  • Therapy area: Myeloid Leukemia

  • Drug types: ONC

  • Lead product: CBX-250

  • Funding: $80M A Jul 2023

  • Investors: MPM BioImpact, Pfizer Ventures, Polaris Partners, BVF Partners, Eli Lilly, Mirae Asset Venture Investment, Mirae Asset Capital


crossbowtx.com

linkedin.com

job board


About:

We identify, validate and prioritize the most promising cancer antigens for our T-Cell Receptor mimetic (TCRm) discovery efforts​.

Crossbow Therapeutics
Director, Translational MedicineDirector, Translational Medici...
Cambridge, MA|31 days ago
Apply


Main
Weekly update

Companies

Recruit

Promote

Harbor ATS/CRM
© 2026 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com